BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Kannan Sridharan, Gowri Sivaramakrishnan, Reginald Paul Sequeira, Abdelaziz Elamin. Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysisPostgraduate Medical Journal 2018; 94(1116): 556 doi: 10.1136/postgradmedj-2018-135967
2
Arya M. Sharma. Differential indications for weight lossCurrent Opinion in Endocrine and Metabolic Research 2019; 4: 58 doi: 10.1016/j.coemr.2018.09.001
3
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese RatsAntioxidants 2019; 8(8): 276 doi: 10.3390/antiox8080276
4
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseasesPhytotherapy Research 2019;  doi: 10.1002/ptr.6598
5
Angelique M. L. Scantlebery, Peter Ochodnicky, Lotte Kors, Elena Rampanelli, Loes M. Butter, Chaima El Boumashouli, Nike Claessen, Gwen J. Teske, Marius A. van den Bergh Weerman, Jaklien C. Leemans, Joris J. T. H. Roelofs, Sandrine Florquin. β-Cyclodextrin counteracts obesity in Western diet-fed mice but elicits a nephrotoxic effectScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53890-z
6
Panyavee Pitisuttithum, Wah Kheong Chan, Panida Piyachaturawat, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Jian Gao Fan, Myeong Jun Song, Seung Kew Yoon, Yock Young Dan, Laurentius Lesmana, Khek Yu Ho, Khean Lee Goh, Vincent Wai Sun Wong, Sombat Treeprasertsuk. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA studyBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01240-z
7
Yala K. Reddy, Hemnishil K. Marella, Yu Jiang, Surosree Ganguli, Peter Snell, Pradeep S.B. Podila, Benedict Maliakkal, Sanjaya K. Satapathy. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver BiopsiesJournal of Clinical and Experimental Hepatology 2020; 10(3): 245 doi: 10.1016/j.jceh.2019.07.002
8
Bokyeong Ryu, Kyung-Yeon Eo, Ja-Jun Jang, C-Yoon Kim, Ji Min Lee, Hanseul Oh, Ukjin Kim, Jin Kim, Hyun-Ho Lee, Young-Mok Jung, Jae-Hak Park. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata )Journal of Medical Primatology 2018; 47(4): 270 doi: 10.1111/jmp.12347
9
Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budriesi, Saeideh Momtaz, Seyed Mohammad Nabavi, Anupam Bishayee. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic DisordersInternational Journal of Molecular Sciences 2019; 20(19): 4957 doi: 10.3390/ijms20194957
10
D.H. Seo, Y.-h. Lee, S.W. Park, Y.J. Choi, B.W. Huh, E. Lee, K.B. Huh, S.H. Kim, B.-S. Cha. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetesDiabetes & Metabolism 2019;  doi: 10.1016/j.diabet.2019.10.004
11
Mohammed F. Abuzinadah, Aftab Ahmad. Pharmacological studies on the efficacy of a thymoquinone‐containing novel polyherbal formulation against cisplatin‐induced hepatorenal toxicity in ratsJournal of Food Biochemistry 2020; 44(2) doi: 10.1111/jfbc.13131
12
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver DiseaseNutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
13
Stefan Drinda, Franziska Grundler, Thomas Neumann, Thomas Lehmann, Nico Steckhan, Andreas Michalsen, Francoise Wilhelmi de Toledo. Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational StudyNutrients 2019; 11(11): 2601 doi: 10.3390/nu11112601
14
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy. Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver DiseaseJournal of Clinical Medicine 2020; 9(2): 314 doi: 10.3390/jcm9020314
15
Alessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, Francesco Massimo Perla, Fabrizio Ceci, Antonio Angeloni, Laura D’Erasmo, Michele Di Martino, Marcello Arca. Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesityPediatric Research 2019; 85(5): 671 doi: 10.1038/s41390-019-0303-1
16
Luis Cano, Juan Pablo Cerapio, Eloy Ruiz, Agnès Marchio, Bruno Turlin, Sandro Casavilca, Luis Taxa, Guillaume Marti, Eric Deharo, Pascal Pineau, Stéphane Bertani. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South AmericaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28286-0
17
Matteo Tardelli, Francesca V. Bruschi, Thierry Claudel, Claudia D. Fuchs, Nicole Auer, Victoria Kunczer, Tatjana Stojakovic, Hubert Scharnagl, Aida Habib, Gernot F. Grabner, Robert Zimmermann, Sophie Lotersztajn, Michael Trauner. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorptionJournal of Lipid Research 2019; 60(7): 1284 doi: 10.1194/jlr.M093369
18
Guillermo Rus, Inas H. Faris, Jorge Torres, Antonio Callejas, Juan Melchor. Why Are Viscosity and Nonlinearity Bound to Make an Impact in Clinical Elastographic Diagnosis?Sensors 2020; 20(8): 2379 doi: 10.3390/s20082379
19
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatmentExpert Review of Gastroenterology & Hepatology 2019; 13(5): 447 doi: 10.1080/17474124.2019.1595589
20
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012Cancer 2020; 126(11): 2666 doi: 10.1002/cncr.32803
21
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugsExpert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
22
SHIKHA SRIVASTAVA, ZEBA SIDDIQI, TARUNA SINGH, LAKSHMI BALA. Beetroot Supplementation on Non - Alcoholic Fatty Liver Disease PatientsCurrent Research in Nutrition and Food Science Journal 2019; 7(1): 96 doi: 10.12944/CRNFSJ.7.1.10
23
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsArchives of Medical Research 2020; 51(1): 82 doi: 10.1016/j.arcmed.2019.12.005
24
Guy Rostoker, Christelle Loridon, Mireille Griuncelli, Clémentine Rabaté, Fanny Lepeytre, Pablo Ureña-Torres, Belkacem Issad, Nasredine Ghali, Yves Cohen. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept StudyEBioMedicine 2019; 39: 461 doi: 10.1016/j.ebiom.2018.11.020
25
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse ModelNutrients 2019; 11(9): 2172 doi: 10.3390/nu11092172
26
Rubén Peña-Vélez, Nayely Garibay-Nieto, Manuel Cal-y-Mayor-Villalobos, Estibalitz Laresgoiti-Servitje, Karen Pedraza-Escudero, María del Carmen García-Blanco, Omar Alfonso Heredia-Nieto, Eréndira Villanueva-Ortega. Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesityJournal of Pediatric Endocrinology and Metabolism 2020; 33(2): 205 doi: 10.1515/jpem-2019-0204
27
Reggiani V. Gonçalves, Jamili D.B. Santos, Natanny S. Silva, Etienne Guillocheau, Robson E. Silva, Thaiany G. Souza-Silva, Rafael F. Oliveira, Eliziária C. Santos, Romulo D. Novaes. Trans-fatty acids aggravate anabolic steroid-induced metabolic disturbances and differential gene expression in muscle, pancreas and adipose tissueLife Sciences 2019; 232: 116603 doi: 10.1016/j.lfs.2019.116603
28
Eline H. van den Berg, Eke G. Gruppen, Richard W. James, Stephan J. L. Bakker, Robin P. F. Dullaart. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterolJournal of Lipid Research 2019; 60(1): 168 doi: 10.1194/jlr.P088997
29
Harshul Pandit, Joseph P. Tinney, Yan Li, Guozhen Cui, Suping Li, Bradley B. Keller, Robert C.G. Martin. Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse ModelsUltrasound in Medicine & Biology 2019; 45(2): 549 doi: 10.1016/j.ultrasmedbio.2018.10.011
30
Rachelle P. Davis, Bas G. J. Surewaard, Madison Turk, Agostina Carestia, Woo-Yong Lee, Björn Petri, Stefan J. Urbanski, Carla S. Coffin, Craig N. Jenne. Optimization of In vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital MicroscopyFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02988
31
Siavash Mehdizadeh Seraj, Abdullah Al-Zaghal, Mahdi Z. Zadeh, Pegah Jahangiri, Kamyar Pournazari, William Y. Raynor, Thomas J. Werner, Poul F. Høilund-Carlsen, Abass Alavi, Stephen J. Hunt. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMINuclear Medicine Communications 2019; 40(5): 545 doi: 10.1097/MNM.0000000000001000
32
Anca Bălănescu, Iustina Stan, Ioana Codreanu, Valentina Comănici, Eugenia Bălănescu, Paul Bălănescu. Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional StudyDisease Markers 2019; 2019: 1 doi: 10.1155/2019/9560247
33
Justin D. Schumacher, Grace L. Guo. Bile Acids and Their ReceptorsHandbook of Experimental Pharmacology 2019; 256: 325 doi: 10.1007/164_2019_228
34
Zeynab Yousefi, Mitra Nourbakhsh, Zohreh Abdolvahabi, Seyedeh‐Sara Ghorbanhosseini, Zahra Hesari, Sahar Yarahmadi, Samira Ezzati‐Mobasser, Parvane Seiri, Mohammad Borji, Reza Meshkani, Mojtaba Malek. microRNA‐141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP‐activated protein kinase pathway in hepatocytesJournal of Cellular Physiology 2020; 235(2): 880 doi: 10.1002/jcp.29002
35
Julie Rask Larsen, Lorena Dima, Christoph U. Correll, Peter Manu. The pharmacological management of metabolic syndromeExpert Review of Clinical Pharmacology 2018; 11(4): 397 doi: 10.1080/17512433.2018.1429910
36
Salwa Seddik Hosny, Hanan Mahmoud Ali, Wesam Ahmed Mohammed, Mohamed Hesham El Ghannam. Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DMDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 1769 doi: 10.1016/j.dsx.2019.04.002
37
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou, Gianfranco D. Alpini. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytesPLOS ONE 2020; 15(5): e0232630 doi: 10.1371/journal.pone.0232630
38
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean PopulationInternational Journal of Environmental Research and Public Health 2020; 17(10): 3518 doi: 10.3390/ijerph17103518
39
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J Lamb, Albert de Roos, Frits R Rosendaal, Renée de Mutsert. Sweet Snacks Are Positively and Fruits and Vegetables Are Negatively Associated with Visceral or Liver Fat Content in Middle-Aged Men and WomenThe Journal of Nutrition 2019; 149(2): 304 doi: 10.1093/jn/nxy260
40
Maria Rubio-Ruiz, Verónica Guarner-Lans, Agustina Cano-Martínez, Eulises Díaz-Díaz, Linaloe Manzano-Pech, Anel Gamas-Magaña, Vicente Castrejón-Tellez, Concepción Tapia-Cortina, Israel Pérez-Torres. Resveratrol and Quercetin Administration Improves Antioxidant DEFENSES and reduces Fatty Liver in Metabolic Syndrome RatsMolecules 2019; 24(7): 1297 doi: 10.3390/molecules24071297
41
Aleksandra Klisic, Ludovico Abenavoli, Sharmila Fagoonee, Nebojsa Kavaric, Gordana Kocic, Ana Ninić. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD scoreMinerva Medica 2019; 110(3) doi: 10.23736/S0026-4806.19.05978-0
42
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese MiceFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
43
O.Ya. Babak, N.M. Zhelezniakova, A.O. Rozhdestvenska . The potential role of kallistatin as a new biomarker in non-invasive diagnostics of non-alcoholic fatty liver disease with hypertensionShidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2019; 2019(2): 18 doi: 10.15407/internalmed2019.02.018
44
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. Bioactive Molecules in FoodReference Series in Phytochemistry 2019; : 295 doi: 10.1007/978-3-319-78030-6_57
45
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overviewJournal of Prescribing Practice 2020; 2(4): 200 doi: 10.12968/jprp.2020.2.4.200
46
Katharina L. Hupa, Elmar Jaeckel, Michael P. Manns. Silymarin for Treatment of Nonalcoholic Steatohepatitis–A New Kid on the Block?Clinical Gastroenterology and Hepatology 2017; 15(12): 1863 doi: 10.1016/j.cgh.2017.08.005
47
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle, Yuriy K. Bashmakov. Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary ReportInternational Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/4549614
48
Ping Ye, Jijun Liu, Wuping Xu, Denghai Liu, Xiangchao Ding, Sheng Le, Hao Zhang, Shanshan Chen, Manhua Chen, Jiahong Xia. Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 SuppressionHepatology 2019; 69(5): 1946 doi: 10.1002/hep.30485
49
Subramaniyam Nithyananthan, Dangudubiyyam Sushmaa, Ibansiewdor Myrthong, Lokanatha Valluru, Shreyoshi Guha, Ishfaq Hassan Mir, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Curcuma longa and Trigonella foenum graecum ‐enriched nutrient mixture from germinated Macrotyloma uniflorum and Vigna radiate ameliorate nonalcoholic fatty liver diseases in rats Journal of Food Biochemistry 2020; 44(4) doi: 10.1111/jfbc.13159
50
Hye In Kim, Jeon-Kyung Kim, Jae-Young Kim, Se-Eun Jang, Myung Joo Han, Dong-Hyun Kim. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in miceNutrition Research 2019; 67: 78 doi: 10.1016/j.nutres.2019.03.008
51
Cíntia Castro-Correia, Rita Santos-Silva, Marta Pinheiro, Carla Costa, Manuel Fontoura. Metabolic risk factors in adolescent girls with type 1 diabetesJournal of Pediatric Endocrinology and Metabolism 2018; 31(6): 631 doi: 10.1515/jpem-2018-0053
52
A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov. EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTSMedical Immunology (Russia) 2019; 21(5): 945 doi: 10.15789/1563-0625-2019-5-945-952
53
Karilyn E. Sant, Hadley M. Moreau, Larissa M. Williams, Haydee M. Jacobs, Anna M. Bowsher, Jason D. Boisvert, Roxanna M. Smolowitz, Jacob Pantazis, Kate Annunziato, Malina Nguyen, Alicia Timme-Laragy. Embryonic exposures to mono-2-ethylhexyl phthalate induce larval steatosis in zebrafish independent of Nrf2a signalingJournal of Developmental Origins of Health and Disease 2020; : 1 doi: 10.1017/S2040174420000057
54
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered viewWorld Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
55
P. Melendez, M. Whitney, F. Williams, P. Pinedo, D. Manriquez, S.G. Moore, M.C. Lucy, P. Pithua, S.E. Poock. Technical note: Evaluation of fine needle aspiration cytology for the diagnosis of fatty liver in dairy cattleJournal of Dairy Science 2018; 101(5): 4483 doi: 10.3168/jds.2017-13346
56
Vik Meadows, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, Heather Francis. Bile Acid Receptor Therapeutics Effects on Chronic Liver DiseasesFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00015
57
David E. Stec, Darren M. Gordon, Jennifer A. Hipp, Stephen Hong, Zachary L. Mitchell, Natalia R. Franco, J. Walker Robison, Christopher D. Anderson, Donald F. Stec, Terry D. Hinds. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2019; 317(5): R733 doi: 10.1152/ajpregu.00153.2019
58
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaAmerican Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
59
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in EgyptAmerican Journal of Biochemistry and Molecular Biology 2018; 8(1): 16 doi: 10.3923/ajbmb.2018.16.22
60
Md Akheruzzaman, Vijay Hegde, Andrew C. Shin, Nikhil V. Dhurandhar. Reducing endogenous insulin is linked with protection against hepatic steatosis in miceNutrition & Diabetes 2020; 10(1) doi: 10.1038/s41387-020-0114-9
61
Bo Wang, Yanghua Qu, Yiping Wang, Yong Ma, Chenchen Xu, Fadi Li, Ce Liu, Xiaonan Lu, Bo Wang, Peng Xiu, Yuefeng Gao, Zhicheng Diao, Yuxia Li, Hailing Luo. Triplet Male Lambs Are More Susceptible than Twins to Dietary Soybean Oil–Induced Fatty LiverThe Journal of Nutrition 2019; 149(6): 989 doi: 10.1093/jn/nxz039
62
E. Cipponeri, N. Vitturi, V. Mariano, F. Boscari, S. Galasso, C. Crepaldi, G. P. Fadini, S. Vigili de Kreutzenberg, M. C. Marescotti, E. Iori, F. Cavallin, L. Sartori, A. Baritussio, A. Avogaro, D. Bruttomesso. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetesJournal of Endocrinological Investigation 2019; 42(9): 1099 doi: 10.1007/s40618-019-01031-8
63
Adryana Cordeiro, Raquel Costa, Nelson Andrade, Cláudia Silva, Natalia Canabrava, Maria João Pena, Ilda Rodrigues, Sara Andrade, Andrea Ramalho. Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?Clinics and Research in Hepatology and Gastroenterology 2020;  doi: 10.1016/j.clinre.2019.10.001
64
Homayoon BASHIRI, Arezoo BOZORGOMID, Vahid SHOJAEIMOTLAGH. Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trialTURKISH JOURNAL OF MEDICAL SCIENCES 2020; 44(2): 354 doi: 10.3906/sag-1907-82
65
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of DiabetesClinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
66
Eline H. van den Berg, James P. Corsetti, Stephan J. L. Bakker, Robin P. F. Dullaart, Petter Bjornstad. Plasma ApoE elevations are associated with NAFLD: The PREVEND StudyPLOS ONE 2019; 14(8): e0220659 doi: 10.1371/journal.pone.0220659
67
Muhammad Amir, Michael Yu, Peijian He, Shanthi Srinivasan. Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver DiseaseFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00062
68
Ashley Cast, Meenasri Kumbaji, Amber D'Souza, Katherine Rodriguez, Anita Gupta, Rebekah Karns, Lubov Timchenko, Nikolai Timchenko. Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver DiseaseHepatology Communications 2019; 3(8): 1036 doi: 10.1002/hep4.1381
69
Resham Ramkissoon, Timothy B. Gardner. Pancreatic SteatosisThe American Journal of Gastroenterology 2019; 114(11): 1726 doi: 10.14309/ajg.0000000000000262
70
Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, Marialuisa Sponziello, Laura D’Erasmo, Licia Polimeni, Francesco Baratta, Daniele Pastori, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Giuseppe Giannini, Maria Del Ben, Francesco Angelico, Marcello Arca. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21939-0
71
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese PatientsCurrent Hepatology Reports 2017; 16(4): 382 doi: 10.1007/s11901-017-0377-3
72
Feng-Juan Yan, Yong-Jian Wang, Shi-Ran Yan, Jun Lu, Yuan-Lin Zheng. ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARαBiochemical Journal 2019; 476(2): 385 doi: 10.1042/BCJ20180517
73
Nuria Perez-Diaz-del-Campo, Itziar Abete, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, M. Angeles Zulet. Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver DiseaseNutrients 2020; 12(5): 1260 doi: 10.3390/nu12051260
74
Maria Kalogirou, Emmanouil Sinakos. Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?World Journal of Hepatology 2018; 10(11): 790-794 doi: 10.4254/wjh.v10.i11.790
75
Beyza Bulutoglu, Camilo Rey-Bedón, Young Bok (Abraham) Kang, Safak Mert, Martin L. Yarmush, O. Berk Usta. A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonationLab on a Chip 2019; 19(18): 3022 doi: 10.1039/C9LC00354A
76
Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae. The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 InhibitionFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00539
77
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver DiseaseAdvanced Biosystems 2019; 3(8): 1900104 doi: 10.1002/adbi.201900104
78
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsThe American Journal of Gastroenterology 2020; 115(4): 562 doi: 10.14309/ajg.0000000000000484
79
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitisF1000Research 2020; 9: 56 doi: 10.12688/f1000research.21918.1
80
Zahra Maleki, Shima Jazayeri, Omid Eslami, Farzad Shidfar, Agha Fatemeh Hosseini, Shahram Agah, Hamed Norouzi. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trialComplementary Therapies in Medicine 2019; 44: 44 doi: 10.1016/j.ctim.2019.02.020
81
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
82
Nahum Mendez-Sanchez, Vania Cruz-Ramon, Oscar Ramirez-Perez, Jessica Hwang, Beatriz Barranco-Fragoso, Jaqueline Cordova-Gallardo. New Aspects of Lipotoxicity in Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2018; 19(7): 2034 doi: 10.3390/ijms19072034
83
Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLDJournal of Clinical Medicine 2020; 9(3): 870 doi: 10.3390/jcm9030870
84
Enxiang Zhang, Shutao Yin, Chong Zhao, Lihong Fan, Hongbo Hu. Involvement of activation of PLIN5-Sirt1 axis in protective effect of glycycoumarin on hepatic lipotoxicityBiochemical and Biophysical Research Communications 2020;  doi: 10.1016/j.bbrc.2020.05.072
85
Juan-Fen Mo, Jia-Yuan Wu, Li Zheng, Ya-Wei Yu, Tian-Xin Zhang, Li Guo, Yi Bao. Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese miceRSC Advances 2018; 8(54): 31194 doi: 10.1039/C8RA05915B
86
Wen-Chung Huang, Ya-Ling Chen, Hui-Chia Liu, Shu-Ju Wu, Chian-Jiun Liou. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cellsSaudi Pharmaceutical Journal 2018; 26(8): 1178 doi: 10.1016/j.jsps.2018.07.006
87
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?Experimental Neurology 2020; 325: 113160 doi: 10.1016/j.expneurol.2019.113160
88
Mark G. Swain, David E. J. Jones. Fatigue in chronic liver disease: New insights and therapeutic approachesLiver International 2019; 39(1): 6 doi: 10.1111/liv.13919
89
Zain Moosvi, Felix H. Lui, Douglas Nguyen. Liver Diseases2020; : 407 doi: 10.1007/978-3-030-24432-3_35
90
Arunaksharan Narayanankutty. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic DiseasesCurrent Drug Targets 2019; 20(10): 1068 doi: 10.2174/1389450120666190222181506
91
Chris Boesch. Quantitative MR Imaging Is Increasingly Important in Liver DiseaseRadiology 2018; 286(2): 557 doi: 10.1148/radiol.2017172312
92
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. SweetenersReference Series in Phytochemistry 2018; : 1 doi: 10.1007/978-3-319-54528-8_57-1
93
Pierangelo Torquato, Desirée Bartolini, Danilo Giusepponi, Marta Piroddi, Bartolomeo Sebastiani, Giorgio Saluti, Roberta Galarini, Francesco Galli. Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjectsFree Radical Biology and Medicine 2019; 131: 115 doi: 10.1016/j.freeradbiomed.2018.11.036
94
Hany A. Abdel Samie, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar, Mohammad A. Kamal. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular CarcinomaCurrent Drug Metabolism 2019; 20(4): 283 doi: 10.2174/1389200220666190308134351
95
Lucas Zangerolamo, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Maria Esméria do Amaral, Everardo Magalhães Carneiro, Sara Teresinha Olalla-Saad, Antonio Carlos Boschero, Helena Cristina Barbosa-Sampaio. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese miceCanadian Journal of Physiology and Pharmacology 2019; 97(11): 1018 doi: 10.1139/cjpp-2018-0691
96
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular CarcinomaCells 2020; 9(2): 262 doi: 10.3390/cells9020262
97
Robin H. Isaacson, Juliane I. Beier, Nicholas KH Khoo, Bruce A. Freeman, Zachary Freyberg, Gavin E. Arteel. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphaneThe Journal of Nutritional Biochemistry 2020; 81: 108399 doi: 10.1016/j.jnutbio.2020.108399
98
Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al-Salami, Karmen Stankov, Momir Mikov. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic SyndromeFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01382
99
Paul F. Lebeau, Jae Hyun Byun, Khrystyna Platko, Melissa E. MacDonald, Samantha V. Poon, Mahi Faiyaz, Nabil G. Seidah, Richard C. Austin. Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in miceJournal of Biological Chemistry 2019; 294(23): 9037 doi: 10.1074/jbc.RA119.008094
100
Berangere Gapp, Marie Jourdain, Pauline Bringer, Benjamin Kueng, Delphine Weber, Arnaud Osmont, Stefan Zurbruegg, Judith Knehr, Rocco Falchetto, Guglielmo Roma, William Dietrich, Reginald Valdez, Nicolau Beckmann, Florian Nigsch, Arun J. Sanyal, Iwona Ksiazek. Farnesoid X Receptor Agonism, Acetyl‐Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH Model Hepatology Communications 2020; 4(1): 109 doi: 10.1002/hep4.1443
101
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J. Lamb, Albert de Roos, Frits R. Rosendaal, Renée de Mutsert. Adherence to dietary guidelines in relation to visceral fat and liver fat in middle-aged men and women: the NEO studyInternational Journal of Obesity 2020; 44(2): 297 doi: 10.1038/s41366-019-0441-x
102
Ji-Youn Kim, Gyu-Na Lee, Hyun Chul Song, Yong-Moon Park, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko. Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination SurveyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60797-7
103
Ceri‐Anne E. Suurmond, Soufian Lasli, Floor W. Dolder, Aly Ung, Han‐Jun Kim, Praveen Bandaru, KangJu Lee, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer CellsAdvanced Healthcare Materials 2019; 8(24): 1901379 doi: 10.1002/adhm.201901379
104
Amir Mohammad Kazemifar, Ali Akbar Shafikhani, Elaheh HajiNoormohammadi, Zahra Azarion, Aliakbar Hajiaghamohammadi. Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trialEgyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0001-z
105
S.M. Touhidul Islam, Jeseong Won, Mushfiquddin Khan, Kenneth D. Chavin, Inderjit Singh. Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitisAnnals of Hepatology 2019;  doi: 10.1016/j.aohep.2019.11.007
106
Yuhei Mizunoe, Masaki Kobayashi, Ryoma Tagawa, Yoshimi Nakagawa, Hitoshi Shimano, Yoshikazu Higami. Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic SyndromeInternational Journal of Molecular Sciences 2019; 20(15): 3688 doi: 10.3390/ijms20153688
107
Shenzong Rao, Jingsong Huang, Zhijun Shen, Changgang Xiang, Min Zhang, Xueliang Lu. Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver diseaseJournal of Cellular Biochemistry 2019; 120(7): 11867 doi: 10.1002/jcb.28468
108
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
109
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overviewGastrointestinal Nursing 2020; 18(2): 22 doi: 10.12968/gasn.2020.18.2.22
110
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
111
M. Bellan, M. Menegatti, C. Ferrari, G.P. Carnevale Schianca, M. Pirisi. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practiceNutrition, Metabolism and Cardiovascular Diseases 2018; 28(6): 610 doi: 10.1016/j.numecd.2018.01.006
112
Cyriac Abby Philips, Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar, Guruprasad Padsalgi, Pushpa Mahadevan. Acute exacerbated severe form of nonalcoholic steatohepatitis leading to acute-on-chronic liver failure: A case seriesIndian Journal of Gastroenterology 2020; 39(1): 97 doi: 10.1007/s12664-020-01028-9
113
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver TissuesApplied In Vitro Toxicology 2018; 4(3): 288 doi: 10.1089/aivt.2018.0015
114
Qian Chen, Mengyang Liu, Haiyang Yu, Jian Li, Sijian Wang, Yi Zhang, Feng Qiu, Tao Wang. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathwayJournal of Natural Medicines 2018; 72(3): 655 doi: 10.1007/s11418-018-1199-5
115
İsa Çam, Ural Koc, Samet Genez, Abdullah Güneş. Computed Tomography Measurements of Hepatic Steatosis in Cholelitihiasis and Cholecystectomy Cases Using Unenhanced ImagesJournal of Medical Imaging and Radiation Sciences 2020; 51(1): 137 doi: 10.1016/j.jmir.2019.12.003
116
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2019; 31(8): 998 doi: 10.1097/MEG.0000000000001319
117
Chang Li, Jing Ye, Yun Peng, Weiqiang Dou, Songan Shang, Jingtao Wu, Ramin Jafari, Kelly McCabe Gillen, Yi Wang, Martin Prince, Xianfu Luo. Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit modelMagnetic Resonance Imaging 2019; 63: 267 doi: 10.1016/j.mri.2019.08.032
118
Imran Nazir Salroo, Musharaf Bashir, Rayees Ahmad Bhat, Sheikh Imran Sayeed, Nazir Ahmad Salroo. Correlates of ultrasound diagnosed non alcoholic fatty liver disease in Indian adults with features of metabolic syndromeJournal of Clinical Medicine of Kazakhstan 2020; 1(55): 17 doi: 10.23950/1812-2892-JCMK-00732
119
Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber Salter, Allan Tsung, Jaquelyn Fleckenstein, Anup S. Shetty, Amir A. Borhani, Alessandro Furlan, Kathryn J. Fowler. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteriaHPB 2019; 21(12): 1697 doi: 10.1016/j.hpb.2019.04.007
120
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage PathwayJournal of Proteome Research 2019;  doi: 10.1021/acs.jproteome.9b00405
121
Di-Shuang Hu, Sheng-Hao Zhu, Xu Li, Qin-Fen Chen, Chun-Jing Lin, Dan-Hong Fang, Jian-Sheng Wu. Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic IndividualsCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/8748459
122
George V. Dedoussis, Athina I. Amanatidou. NAFLD and NASH2020; : 181 doi: 10.1007/978-3-030-37173-9_10
123
Yi-Hsien Chang, Ya-Ling Chen, Wen-Chung Huang, Chian-Jiun Liou. Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathwayBiochemical and Biophysical Research Communications 2018; 495(1): 197 doi: 10.1016/j.bbrc.2017.11.022
124
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid SupplementationNutrients 2019; 11(4): 872 doi: 10.3390/nu11040872
125
Marco Raffaele, Lars Bellner, Shailendra P. Singh, Gaia Favero, Rita Rezzani, Luigi Fabrizio Rodella, John R. Falck, Nader G. Abraham, Luca Vanella. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1α mitochondrial signalingExperimental Cell Research 2019; 380(2): 180 doi: 10.1016/j.yexcr.2019.04.029
126
Arne Janssen, Diederick E Grobbee, Paul Dendale. Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular diseaseEuropean Journal of Preventive Cardiology 2019; : 204748731989178 doi: 10.1177/2047487319891783
127
Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov. Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromesDiabetes mellitus 2018; 20(6): 449 doi: 10.14341/DM9374
128
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseasesAdvanced Drug Delivery Reviews 2019; : 72 doi: 10.1016/j.addr.2019.11.001
129
Eréndira Villanueva-Ortega, María José Garcés-Hernández, Arturo Herrera-Rosas, Juan Carlos López-Alvarenga, Estibalitz Laresgoiti-Servitje, Galileo Escobedo, Gloria Queipo, Sergio Cuevas-Covarrubias, Guadalupe Nayely Garibay-Nieto. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric populationAnnals of Hepatology 2019; 18(5): 693 doi: 10.1016/j.aohep.2019.04.012
130
Mohamed Mostafa, Amrou Abdelkader, John J. Evans, Catherine E. Hagen, Christopher P. Hartley. Fatty Liver Disease: A Practical ApproachArchives of Pathology & Laboratory Medicine 2020; 144(1): 62 doi: 10.5858/arpa.2019-0341-RA
131
Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen, Robin P. F. Dullaart. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver diseaseEuropean Journal of Clinical Investigation 2018; 48(9): e12988 doi: 10.1111/eci.12988
132
Carolyne Pimentel Rosado, Victor Hugo Cordeiro Rosa, Bruna Cadete Martins, Aruanna Cajaty Soares, Izabelle Barcellos Santos, Elisa Bernardes Monteiro, Nathália Moura-Nunes, Cristiane Aguiar da Costa, Alessandra da Rocha Pinheiro Mulder, Julio Beltrame Daleprane. Resistant starch from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity in miceInternational Journal of Biological Macromolecules 2020; 145: 1066 doi: 10.1016/j.ijbiomac.2019.09.199
133
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólicoRevista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
134
Elizabeth J. Millings, Maria Caterina De Rosa, Sarah Fleet, Kazuhisa Watanabe, Richard Rausch, Dieter Egli, Gen Li, Charles A. Leduc, Yiying Zhang, Stuart G. Fischer, Rudolph L. Leibel, Leonidas G. Koniaris. ILDR2 has a negligible role in hepatic steatosisPLOS ONE 2018; 13(5): e0197548 doi: 10.1371/journal.pone.0197548
135
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
136
Eline H. van den Berg, Eke G. Gruppen, Sanam Ebtehaj, Stephan J.L. Bakker, Uwe J.F. Tietge, Robin P.F. Dullaart. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver diseaseAtherosclerosis 2018; 277: 21 doi: 10.1016/j.atherosclerosis.2018.07.028
137
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
138
Junli Zhang, Haiming Zhang, Xiaoling Deng, Ning Zhang, Beibei Liu, Shengliang Xin, Guixin Li, Keshu Xu. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in miceLife Sciences 2018; 192: 46 doi: 10.1016/j.lfs.2017.11.027
139
Shu Liang, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut MicrobiotaEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/5378961
140
Rose Ghemrawi, Shyue-Fang Battaglia-Hsu, Carole Arnold. Endoplasmic Reticulum Stress in Metabolic DisordersCells 2018; 7(6): 63 doi: 10.3390/cells7060063
141
Hwa-Young Lee, Geum-Hwa Lee, Young Yoon, Han-Jung Chae. Rhus verniciflua and Eucommia ulmoides Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK ActivationThe American Journal of Chinese Medicine 2019; 47(06): 1253 doi: 10.1142/S0192415X19500642
142
Ernesto Cortes, Dariusz Lachowski, Alistair Rice, Antonios Chronopoulos, Benjamin Robinson, Stephen Thorpe, David A Lee, Lucia A Possamai, Haiyun Wang, David J Pinato, Armando E. del Río Hernández. Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate CellsHepatology 2019; 69(2): 785 doi: 10.1002/hep.30193
143
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis ( NASH ) Pharmacology Research & Perspectives 2019; 7(3): e00485 doi: 10.1002/prp2.485
144
S. Maâlej, S. Jedidi, H. Hannachi, H. Gharsalli, I. Sahnoun, H. Neji, L. El Gharbi. Prévalence et facteurs de risque de stéatose hépatique chez les adultes tunisiens atteints de syndrome d’apnées hypopnées obstructives du sommeilRevue des Maladies Respiratoires 2020; 37(1): 8 doi: 10.1016/j.rmr.2019.11.643
145
Esteban Porrini, Maruja Navarro-Díaz, Rosa Rodríguez-Rodríguez, Eduardo Salido. Diabetic Nephropathy2019; : 65 doi: 10.1007/978-3-319-93521-8_5
146
Yoosoo Chang, Jin-Won Noh, Joo Young Cheon, Yejin Kim, Young Dae Kwon, Seungho Ryu. Self-rated health and risk of incident non-alcoholic fatty liver disease: A cohort studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60823-8
147
Michelle L. Parker, Khosrow Adeli, Émile Lévy, Edgard Delvin. Are universal upper reference limits for alanine aminotransferase (ALT) appropriate for assessing pediatric liver injury?Clinical Biochemistry 2018; 53: 55 doi: 10.1016/j.clinbiochem.2018.01.010
148
Avner Ehrlich, Sabina Tsytkin-Kirschenzweig, Konstantinos Ioannidis, Muneef Ayyash, Anne Riu, Reine Note, Gladys Ouedraogo, Jan Vanfleteren, Merav Cohen, Yaakov Nahmias. Microphysiological flux balance platform unravels the dynamics of drug induced steatosisLab on a Chip 2018; 18(17): 2510 doi: 10.1039/C8LC00357B
149
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenInternational Journal of Molecular Sciences 2019; 20(18): 4444 doi: 10.3390/ijms20184444
150
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han PopulationJournal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2019.00010
151
Damien Viglino, Anais Plazanet, Sebastien Bailly, Meriem Benmerad, Ingrid Jullian-Desayes, Renaud Tamisier, Vincent Leroy, Jean-Pierre Zarski, Maxime Maignan, Marie Joyeux-Faure, Jean-Louis Pépin. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary DiseaseScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34988-2
152
Isabel Hidalgo, Nayelli Nájera, Eduardo Meaney, Javier Pérez-Durán, Yolotzin Valdespino-Vazquez, Francisco Villarreal, Guillermo Ceballos. Effects of (−)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitisThe Journal of Nutritional Biochemistry 2020; 77: 108296 doi: 10.1016/j.jnutbio.2019.108296
153
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology2019; : 21 doi: 10.1002/cphy.c190007
154
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
155
Seon-Heui Cha, Yongha Hwang, Soo-Jin Heo, Hee-Sook Jun. Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic InflammationMarine Drugs 2019; 17(9): 486 doi: 10.3390/md17090486
156
Patrick C. Turnbull, Ali C. Dehghani, Christopher F. Theriau, Michael K. Connor, Christopher G. R. Perry. Synergistic activation of mitochondrial metabolism and the glutathione redox couple protects HepG2 hepatocarcinoma cells from palmitoylcarnitine-induced stressAmerican Journal of Physiology-Cell Physiology 2019; 317(6): C1324 doi: 10.1152/ajpcell.00366.2019
157
Ludivine Renaud, Willian A. da Silveira, E. Starr Hazard, Jonathan Simpson, Silvia Falcinelli, Dongjun Chung, Oliana Carnevali, Gary Hardiman. The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNomeGenes 2017; 8(10): 269 doi: 10.3390/genes8100269
158
Cong Wang, Shousheng Liu, Linlin Lu, Songling Liao, Haiyan Yue, Quanjiang Dong, Yongning Xin, Shiying Xuan. Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han PopulationHepatitis Monthly 2018; 18(6) doi: 10.5812/hepatmon.66149